Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Total 13F shares
-
19,740,280
-
Share change
-
+2,030,055
-
Total reported value
-
$590,138,252
-
Price per share
-
$29.90
-
Number of holders
-
57
-
Value change
-
+$57,754,634
-
Number of buys
-
34
-
Number of sells
-
13
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q1 2022
As of 31 Mar 2022,
Immunocore Holdings plc - Ordinary shares (IMCR) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,740,280 shares.
The largest 10 holders included
Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, FMR LLC, Avidity Partners Management LP, WELLINGTON MANAGEMENT GROUP LLP, GENERAL ATLANTIC, L.P., FIRST MANHATTAN CO, Bill & Melinda Gates Foundation, and Paradigm Biocapital Advisors LP.
This page lists
57
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.